XBP1 and leukemia: Addition of 10 μM sorafenib to human leukemia U937, Jurkat, and K562 cells was found to result in rapid accumulation of IRE1α protein and more moderate XBP1 expression, similar to application of the well-known ER stress inducers, thapsigargin, or tunicamycin.